Therefore, our study provided a novel link between SPOP/CHAF1A axis and tumor autophagy of DLBCL, acting as the basis for finding novel epigenetic targets for DLBCL treatment. The gene discussed is CHAF1A; the disease is diffuse large B-cell lymphoma.